Transparency in clinical trials is continually changing, and to stay on top of the news, TrialAssure brings a weekly round-up of some of the key stories surrounding disclosures in clinical trials. This week’s stories are as follows:
New process for registering a new or development substance in EudraCT – EudraCT
As of July 26, EudraCT has implemented a new process for registering a new or development substance. Now, sponsors of clinical trials must request development substances in advance if they wish to submit a clinical trial application in EudraCT or an Investigational Medicinal Product in XEVMPD.
Read the news update here
New PRS guided tutorials – ClinicalTrials.gov
ClinicalTrials.gov recently announced the launch of a new tool to help PRS users enter their results information. A new beta version of PRS guided tutorials are now available on the PRS website.
Follow the news at clinicaltrials.gov
Open data critical to clinical research – Duke Clinical Research Institute
In a recent article, Frank Rockhold, PhD of the Duke Clinical Research Institute described why data sharing is vital to clinical research. Along with three other article contributors, Rockhold lists strengths and weaknesses of current data access platforms and gives recommendations for the future.
Read Frank Rockhold’s insights here